These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15736429)

  • 1. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.
    Han EK; Mcgonigal T; Wang J; Giranda VL; Luo Y
    Anticancer Res; 2004; 24(6):3899-905. PubMed ID: 15736429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
    Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
    Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.
    Huang YT; Lee LT; Lee PP; Lin YS; Lee MT
    Anticancer Res; 2005; 25(3B):2017-25. PubMed ID: 16158939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion, actin cytoskeleton organisation and the spreading of colon adenocarcinoma cells induced by EGF are mediated by alpha2beta1 integrin low clustering through focal adhesion kinase.
    Pichard V; Honoré S; Kovacic H; Li C; Prevôt C; Briand C; Rognoni JB
    Histochem Cell Biol; 2001 Oct; 116(4):337-48. PubMed ID: 11702192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factors stimulate kidney proximal tubule cell migration independent of augmented tyrosine phosphorylation of focal adhesion kinase.
    Cao Y; Baig MR; Hamm LL; Wu K; Simon EE
    Biochem Biophys Res Commun; 2005 Mar; 328(2):560-6. PubMed ID: 15694384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
    Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
    Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.
    van Nimwegen MJ; Verkoeijen S; van Buren L; Burg D; van de Water B
    Cancer Res; 2005 Jun; 65(11):4698-706. PubMed ID: 15930288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
    Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
    Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of focal adhesion kinase (pp125(FAK)) is increased in human keratinocytes induced to migrate by extracellular matrices.
    Yurko MA; O'Toole EA; Woodley DT
    J Cell Physiol; 2001 Jul; 188(1):24-32. PubMed ID: 11382919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells.
    Lee LT; Huang YT; Hwang JJ; Lee AY; Ke FC; Huang CJ; Kandaswami C; Lee PP; Lee MT
    Biochem Pharmacol; 2004 Jun; 67(11):2103-14. PubMed ID: 15135307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
    Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
    Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
    Brunton VG; Ozanne BW; Paraskeva C; Frame MC
    Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells.
    Carloni V; Mazzocca A; Pantaleo P; Cordella C; Laffi G; Gentilini P
    Hepatology; 2001 Jul; 34(1):42-9. PubMed ID: 11431732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The focal adhesion kinase--a regulator of cell migration and invasion.
    Hauck CR; Hsia DA; Schlaepfer DD
    IUBMB Life; 2002 Feb; 53(2):115-9. PubMed ID: 12049193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.
    Ilić D; Furuta Y; Kanazawa S; Takeda N; Sobue K; Nakatsuji N; Nomura S; Fujimoto J; Okada M; Yamamoto T
    Nature; 1995 Oct; 377(6549):539-44. PubMed ID: 7566154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAK integrates growth-factor and integrin signals to promote cell migration.
    Sieg DJ; Hauck CR; Ilic D; Klingbeil CK; Schaefer E; Damsky CH; Schlaepfer DD
    Nat Cell Biol; 2000 May; 2(5):249-56. PubMed ID: 10806474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of focal adhesion kinase expression correlates with changes in the cytoskeleton but not apoptosis in primary cultures of chick embryo cells.
    Ridyard MS; Sanders EJ
    Cell Biol Int; 2001; 25(3):215-26. PubMed ID: 11352494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells.
    Shatz M; Lustig G; Reich R; Liscovitch M
    Exp Cell Res; 2010 Jun; 316(10):1748-62. PubMed ID: 20153318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.